Phathom Pharmaceuticals SEC filings

Filter: All · 8-K · 10-Q · 10-K · Form 4

8-KOct. 26, 2026, 6:02 a.m. ETView on SEC.gov
Other events
AI summary, unreviewedPhathom Pharmaceuticals Discloses FDA Public Docket on VOQUEZNA NCE Exclusivity Challenge by BDR, Comments Due November 23, 2026
8-KOct. 23, 2026, 5 p.m. ETView on SEC.gov
Other events
AI summary, unreviewedPhathom Pharmaceuticals Faces BDR Lawsuit Challenging VOQUEZNA GAIN Act NCE Exclusivity Through May 3, 2032
4Oct. 8, 2026, 5:44 p.m. ETView on SEC.gov
8-KSept. 29, 2026, 4:45 p.m. ETView on SEC.gov
Other events
4Sept. 8, 2026, 4:30 p.m. ETView on SEC.gov
10-QJuly 30, 2026, 7:05 a.m. ETView on SEC.gov
8-KJuly 30, 2026, 7:05 a.m. ETView on SEC.gov
Results of operations and financial condition · Financial statements and exhibits
SCHEDULE 13GJuly 29, 2026, 3:19 p.m. ETView on SEC.gov